Turning Point Brands Q4 net sales up 29% to $121M; Modern Oral surges 266%

Turning Point Brands, Inc.

Q4 net sales $121.0M (+29.2% YoY); net income $8.2M (+239.8%); adjusted EBITDA $30.0M (+14.4%).
Modern Oral net sales $41.3M in Q4 (+265.5% YoY); now 34% of total net sales.
FY 2025 net sales $463.1M (+28.4%); adjusted EBITDA $119.5M (+14.4%); diluted EPS $3.11 vs $2.14.
FY 2026 guidance: Modern Oral net revenue $180-$190M; Q1 2026 adj. EBITDA expected $24-$27M.
Stoker's segment Q4 net sales $81.0M (+69.5%); Zig-Zag segment $40.0M (-12.8%).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.